IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

Tuesday, Dec 9, 2025 2:01 pm ET1min read
IGC--

IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

IGC Pharma: Ascendiant Capital Raises Buy Rating, PT to $4.75.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet